No.8
公告
2026/11/12 17:40
事業の状況
VOLUNTARY ANNOUNCEMENT LATEST RESEARCH AND DEVELOPMENT PROGRESS OF CORE PRODUCTS RIFASUTENIZOL (TNP-2198) AND RIFAQUIZINONE (TNP-2092)
📄 打开公告原文
删除
No.7
公告
2026/10/30 13:05
事業の状況
VOLUNTARY ANNOUNCEMENT DEVELOPMENT OF RIFAQUIZINONE (TNP-2092) ADMINISTERED VIA INTRA-ARTICULAR INJECTION FOR THE TREATMENT OF PROSTHETIC JOINT INFECTION AS A PRIORITY INDICATION
📄 打开公告原文
删除
No.6
公告
2026/10/26 18:02
その他
VOLUNTARY ANNOUNCEMENT H SHARE REPURCHASE PLAN
📄 打开公告原文
删除
No.5
公告
2026/10/23 20:36
定款の変更/臨時株主総会の結果/株式報酬制度
POLL RESULTS OF THE 2026 SECOND EXTRAORDINARY GENERAL MEETING HELD ON FRIDAY, OCTOBER 23, 2026 AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION
📄 打开公告原文
删除
No.4
公告
2026/10/23 09:01
事業の状況
VOLUNTARY ANNOUNCEMENT COMPLETION OF ENROLLMENT OF THE FIRST PATIENT IN THE MULTI-CENTER PHASE IIB CLINICAL TRIAL OF RIFAQUIZINONE (TNP-2092) ADMINISTERED VIA INTRA-ARTICULAR INJECTION FOR THE TREATMENT OF PROSTHETIC JOINT INFECTION
📄 打开公告原文
删除
No.3
公告
2026/10/02 17:32
臨時株主総会の招集/株主名簿の閉鎖
NOTICE OF 2026 SECOND EXTRAORDINARY GENERAL MEETING
📄 打开公告原文
删除
No.2
公告
2026/09/24 17:52
中間報告書
2026 INTERIM REPORT
📄 打开公告原文
删除
No.1
公告
2026/09/21 22:59
定款の変更/株式報酬制度
(1) FORMULATION OF THE 2026 H SHARE AWARD SCHEME; AND (2) AMENDMENTS TO THE ARTICLES OF ASSOCIATION
📄 打开公告原文
删除